Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Novo Nordisk secures exclusive global license from Hengrui Pharma for once-weekly oral GLP-1/GIP dual agonist HRS-1596


Astellas begins Phase III trial of setidegrasib in KRAS G12D mutated advanced lung cancer


EMPAVELI reduces proteinuria and stabilises kidney function in adolescents with C3G or primary IC MPGN


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Process Analytical Technologies – Advances in Bioprocess Integration to Transition to Digital Manufacturing

Presented by Marina Kirkitadze, Head of Process Support & PAT Platform, Analytical Sciences at Sanofi Pasteur and Gabriella Gerzon, PhD Candidate, York University, Toronto, Canada, and Martin Gadsby, Vice President , Optimal Industrial Technologies Ltd
25th January 2023


Mycoplasma Testing: Past, Current, and Future State

Presented by Kenneth Tai, Senior Manager, Analytical Science and Technology at Kite Pharma, Lori Daane, Pharma Microbiology Scientific Director at bioMérieux and Alexander Bartes, Senior Manager Global Analytical Science and Technology (gASAT), Global Quality Control, Roche Pharma
29th April 2021


Modernizing Biopharmaceutical Manufacturing: from Batch to Continuous Production

Presented by Robert Dream, PE, CPIP, of HDR Company, LLC
19th July 2017


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia